Literature DB >> 32613216

Novel copper-based and pH-sensitive nanomedicine for enhanced chemodynamic therapy.

Li Wang1, Zhicheng Zhang1, Yawen Ding1, Jinhui Wu2, Yiqiao Hu2, Ahu Yuan2.   

Abstract

We utilized albumin as a reducing agent to establish novel copper-based and pH-sensitive nanocarrier CuNPs with abundant Cu+, which can encapsulate histone deacetylase (HDAC) inhibitor vorinostat to form uniform and stable nanomedicine V-CuNPs for synergistic chromatin remodelling and chemodynamic therapy.

Entities:  

Year:  2020        PMID: 32613216     DOI: 10.1039/d0cc00165a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  2 in total

1.  Atom-precise fluorescent copper cluster for tumor microenvironment targeting and transient chemodynamic cancer therapy.

Authors:  Zhenzhen Yang; Anli Yang; Wang Ma; Kai Ma; Ya-Kun Lv; Peng Peng; Shuang-Quan Zang; Bingjie Li
Journal:  J Nanobiotechnology       Date:  2022-01-06       Impact factor: 10.435

Review 2.  Recent advances of cancer chemodynamic therapy based on Fenton/Fenton-like chemistry.

Authors:  Changyu Cao; Xiaorui Wang; Nan Yang; Xuejiao Song; Xiaochen Dong
Journal:  Chem Sci       Date:  2021-11-29       Impact factor: 9.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.